Delivery Order SPE2DR25D1100-SPE2DR26FCS1F
- Not listed
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed-price contract, with an ultimate completion date of October 20, 2025, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award was competitively made with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $29,822.56 and is structured under a firm fixed-price arrangement, with an ultimate completion date of October 20, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $7,965.80 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Erleada 60 mg tablets (120-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 26, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $23,245.17 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitive award, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for Erleada 60 mg tablets (120 count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120 count) with an ultimate completion date of May 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $7,352.49 delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of Erleada 240 mg tablets, with a completion date of November 24, 2025. This non-set-aside, firm fixed-price contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) with a completion date of September 4, 2025. This competitive award, issued on August 13, 2025, carries firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed price contract, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $7,965.80 to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Erleada 60 mg tablets (120 count). The contract carries a firm fixed price and is scheduled for completion by December 18, 2025. This non-set-aside delivery order represents a competitive award supporting the federal government's pharmaceutical supply chain requirements through AmerisourceBergen's established distribution infrastructure located in...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS1FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,965.80 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120 count) on December 1, 2025, with completion scheduled for December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's established role as a major pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The award reflects the company's capacity to supply brand-name medications across multiple therapeutic domains through DLA's comprehensive global pharmaceutical support vehicle. As a non-set-aside award, this order demonstrates AmerisourceBergen's continued competitiveness in open federal procurement processes for specialized pharmaceutical products serving Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 11/30/25 |